Community Contributor
Member since 2022
Views450Total number of views
Followers25Total number of followers
Comments0Total number of comments
Subscribers0Total number of subscribers

Is a bird in the hand worth two in the bush?

No link added
LGP logo
Little Green Pharma

Little Green Pharma set to double revenue amidst European expansion

Forecasts for Growth, Future Revenue, Net Profit, and Key Metrics Forecasting LGP’s future performance involves assumptions based on FY2024 trends, market conditions, and strategic plans. Below are speculative projections for key metrics: Revenue Growth: FY2024 Baseline: $25.6 million, up 29% from $19.9 million in FY2023.Read more

View narrative
450
users have viewed this narrative
2users have liked this narrative
1users have commented on this narrative
26users have followed this narrative
AU$0.42
76.9% undervalued intrinsic discount
Fair Value
Profit Margin
14.95%
Future PE
22.04x
Price in 2030
AU$0.57